PYRENE-LINKED PYRROLO[2,1--C][1,4]BENZODIAZEPINE HYBRIDS USEFUL AS ANTI-CANCER AGENTS
申请人:COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
公开号:US20040192677A1
公开(公告)日:2004-09-30
The present invention relates to a process for the preparation of novel pyrrolo [2,1 -c][1,4]benzodiazepine hybrids useful as antitumour agents. This invention also relates to a process for the preparation of new pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential antitumour agents. More particularly, it provides a process for the preparation of 7-methoxy-8-[N-(1″-pyrenyl)-alkane-3′-carboxamide]-oxy-(11aS)-1,2,3,11a-tetraydro 5H-pyrrolo[2,1 -c][1,4]benzodiazepin-5-one, with aliphatic chain length variation of these compounds and it also describes the DNA binding, aticancer (antitumour) activity. The structral formula of this novel pyrrolo[2,1-c][1,4]benzodiazepine is given below:
1
本发明涉及一种制备新型吡咯并[2,1-c][1,4]苯二氮平杂化物的过程,该杂化物可用作抗肿瘤药物。本发明还涉及一种制备新型吡咯并[2,1-c][1,4]苯二氮平杂化物的过程,作为潜在的抗肿瘤药物。更具体地,它提供了一种制备7-甲氧基-8-[N-(1″-芘基)-烷基-3′-羧酰胺]-氧-(11aS)-1,2,3,11a-四氢-5H-吡咯并[2,1-c][1,4]苯并噻唑-5-酮的过程,这些化合物的脂肪链长度变化,以及它还描述了DNA结合,抗癌(抗肿瘤)活性。这种新型吡咯并[2,1-c][1,4]苯二氮平杂化物的结构式如下:1